Back to results

CompletedPhase 3

A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

NCT02452632

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Site KR00019

Dong Gu Gwangju, Dong Gu Gwangju, South Korea

+21 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2015-06-22
Enrollment: 143 participants
Sponsor: Astellas Pharma Korea, Inc.
Purpose: treatment

Locations (22)

Site KR00019Dong Gu Gwangju, Dong Gu Gwangju, South Korea
Site KR00008Gangwon-do, Gangwon-do, South Korea
Site KR00020Jeollabuk-do, Jeollabuk-do, South Korea
Site KR00021Kyungsangnam-do, Kyungsangnam-do, South Korea
Site KR00002Busan, South Korea
Site KR00003Busan, South Korea
Site KR00007Daegu, South Korea
Site KR00011Daegu, South Korea
Site KR00018Gyeonggi-do, South Korea
Site KR00022Gyeonggi-do, South Korea
Site KR00014Incheon, South Korea
Site KR00001Seoul, South Korea
Site KR00004Seoul, South Korea
Site KR00005Seoul, South Korea
Site KR00006Seoul, South Korea
Site KR00009Seoul, South Korea
Site KR00010Seoul, South Korea
Site KR00012Seoul, South Korea
Site KR00013Seoul, South Korea
Site KR00016Seoul, South Korea
Site KR00017Seoul, South Korea
Site KR00015Suwon, South Korea

A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin — TrialFind